intoDNA Presents Data on Two Novel Assays, sSTRIDE-NER and sSTRIDE-PARP1, in Poster Presentations at the 2026 AACR Annual Meeting
intoDNA, a global precision medicine company that provides biopharma and clinicians with decision-grade insights into DNA damage and repair biology to reduce risk, accelerate timelines, and enable truly precise patient care, will present two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, being held April 17-22, 2026 in San Diego, California.
intoDNA to Present Two Poster Presentations at the 2026 AACR Annual Meeting
intoDNA, a global precision medicine company that provides biopharma and clinicians with decision-grade insights into DNA damage and repair biology to reduce risk, accelerate timelines, and enable truly precise patient care, today announced two poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting, being held April 17-22, 2026 in San Diego, California.
